Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Performance Status on Oncologic Outcomes in Patients with Advanced Urothelial Carcinoma Treated with Immune Checkpoint Inhibitor: A Systematic Review and Meta-analysis.
Kawada T, Yanagisawa T, Mostafaei H, Sari Motlagh R, Quhal F, Rajwa P, Laukhtina E, von Deimling M, Bianchi A, Majdoub M, Pallauf M, Pradere B, Teoh JY, Karakiewicz PI, Araki M, Shariat SF. Kawada T, et al. Among authors: karakiewicz pi. Eur Urol Focus. 2023 Mar;9(2):264-274. doi: 10.1016/j.euf.2023.01.019. Epub 2023 Feb 9. Eur Urol Focus. 2023. PMID: 36774273 Review.
Effect of positive surgical margins at radical prostatectomy on cancer-specific mortality in high/very high-risk prostate cancer patients with Gleason Grade Group 4-5.
Panunzio A, Sorce G, Hoeh B, Hohenhorst L, Tappero S, Nimer N, Rajwa P, Tian Z, Terrone C, Chun FKH, Briganti A, Saad F, Shariat SF, Cerruto MA, Antonelli A, Karakiewicz PI. Panunzio A, et al. Among authors: karakiewicz pi. Prostate. 2023 Feb;83(3):268-276. doi: 10.1002/pros.24458. Epub 2022 Nov 6. Prostate. 2023. PMID: 36336728
Biological and prognostic implications of biopsy upgrading for high-grade upper tract urothelial carcinoma at nephroureterectomy.
Katayama S, Pradere B, Grossman NC, Potretzke AM, Boorjian SA, Ghoreifi A, Daneshmand S, Djaladat H, Sfakianos JP, Mari A, Khene ZE, D'Andrea D, Hayakawa N, Breda A, Fontana M, Fujita K, Antonelli A, van Doeveren T, Steinbach C, Mori K, Laukhtina E, Rouprêt M, Margulis V, Karakiewicz PI, Araki M, Compérat E, Nasu Y, Shariat SF. Katayama S, et al. Among authors: karakiewicz pi. Int J Urol. 2023 Jan;30(1):63-69. doi: 10.1111/iju.15061. Epub 2022 Nov 9. Int J Urol. 2023. PMID: 36349904 Free PMC article.
Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer.
Flammia RS, Chierigo F, Würnschimmel C, Wenzel M, Horlemann B, Tian Z, Borghesi M, Leonardo C, Tilki D, Shariat SF, Anceschi U, Chun FKH, Terrone C, Saad F, Gallucci M, Karakiewicz PI. Flammia RS, et al. Among authors: karakiewicz pi. Cent European J Urol. 2022;75(3):240-247. doi: 10.5173/ceju.2022.0053. Epub 2022 Jul 18. Cent European J Urol. 2022. PMID: 36381153 Free PMC article.
Cancer specific mortality in patients with collecting duct vs. clear cell renal carcinoma.
Panunzio A, Sorce G, Tappero S, Hohenhorst L, Garcia CC, Piccinelli M, Tian Z, Tafuri A, De Cobelli O, Chun FKH, Tilki D, Terrone C, Briganti A, Kapoor A, Saad F, Shariat SF, Cerruto MA, Antonelli A, Karakiewicz PI. Panunzio A, et al. Among authors: karakiewicz pi. Cancer Epidemiol. 2023 Feb;82:102297. doi: 10.1016/j.canep.2022.102297. Epub 2022 Nov 16. Cancer Epidemiol. 2023. PMID: 36401949
Conditional survival after radical cystectomy for non-metastatic muscle-invasive squamous cell carcinoma of the urinary bladder: A population-based analysis.
Barletta F, Tappero S, Panunzio A, Incesu RB, Cano Garcia C, Piccinelli ML, Tian Z, Gandaglia G, Moschini M, Terrone C, Antonelli A, Tilki D, Chun FKH, De Cobelli O, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Barletta F, et al. Among authors: karakiewicz pi. Urol Oncol. 2023 Mar;41(3):147.e1-147.e6. doi: 10.1016/j.urolonc.2022.10.027. Epub 2022 Nov 22. Urol Oncol. 2023. PMID: 36428165
Contemporary conditional cancer-specific survival rates in surgically treated adrenocortical carcinoma patients: A stage-specific analysis.
Panunzio A, Barletta F, Tappero S, Cano Garcia C, Piccinelli M, Incesu RB, Law KW, Tian Z, Tafuri A, Tilki D, De Cobelli O, Chun FKH, Terrone C, Briganti A, Saad F, Shariat SF, Bourdeau I, Cerruto MA, Antonelli A, Karakiewicz PI. Panunzio A, et al. Among authors: karakiewicz pi. J Surg Oncol. 2023 Mar;127(4):560-567. doi: 10.1002/jso.27161. Epub 2022 Nov 26. J Surg Oncol. 2023. PMID: 36434748
Collecting duct carcinoma: Epidemiology, clinical characteristics and survival.
Panunzio A, Tappero S, Hohenhorst L, Cano Garcia C, Piccinelli M, Barletta F, Tian Z, Tafuri A, Briganti A, De Cobelli O, Chun FKH, Tilki D, Terrone C, Kapoor A, Saad F, Shariat SF, Cerruto MA, Antonelli A, Karakiewicz PI. Panunzio A, et al. Among authors: karakiewicz pi. Urol Oncol. 2023 Feb;41(2):110.e7-110.e14. doi: 10.1016/j.urolonc.2022.11.009. Epub 2022 Nov 28. Urol Oncol. 2023. PMID: 36456452
A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer.
Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Motlagh RS, Laukhtina E, Rajwa P, Deimling MV, Bianchi A, Pallauf M, Majdoub M, Pradere B, Moschini M, Karakiewicz PI, Teoh JY, Miki J, Kimura T, Shariat SF. Yanagisawa T, et al. Among authors: karakiewicz pi. Eur Urol Focus. 2023 May;9(3):463-479. doi: 10.1016/j.euf.2022.12.003. Epub 2022 Dec 12. Eur Urol Focus. 2023. PMID: 36517409 Free article. Review.
Predictive and Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Muscle Invasive Bladder Cancer Treated With Neoadjuvant Chemotherapy and Radical Cystectomy.
von Deimling M, Schuettfort VM, D'Andrea D, Pradere B, Grossmann NC, Kawada T, Yanagisawa T, Majdoub M, Laukhtina E, Rajwa P, Quhal F, Mostafaei H, Fajkovic H, Teoh JY, Moschini M, Karakiewicz PI, Fisch M, Rink M, Shariat SF. von Deimling M, et al. Among authors: karakiewicz pi. Clin Genitourin Cancer. 2023 Aug;21(4):430-441. doi: 10.1016/j.clgc.2023.01.008. Epub 2023 Jan 26. Clin Genitourin Cancer. 2023. PMID: 36781346
1,376 results